Syra Health Corp. Class A Common Stock (SYRA)
USD 0.38
(-3.8%)
USD 0.38
(-3.8%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 5.51 Million | 5.61 Million | 1.4 Million | - |
| Cost of Revenue | 4.1 Million | 4.55 Million | 979.62 Thousand | - |
| Gross Profit | 1.41 Million | 1.06 Million | 430.35 Thousand | - |
| Operating Expenses | 4.29 Million | 3.15 Million | 433.63 Thousand | 4267.00 |
| Selling, General and Administrative Expenses | 4 Million | 3.1 Million | 416 Thousand | 4267.00 |
| Research and Development Expenses | 240.04 Thousand | - | - | - |
| Other Expenses | - | - | - | - |
| Cost and Expenses | 8.4 Million | 7.7 Million | 1.41 Million | 4267.00 |
| Operating Income | -2.88 Million | -2.08 Million | -3280.00 | -4270.00 |
| Interest Expense | 53.68 Thousand | 28.53 Thousand | - | - |
| Income Tax Expense | - | 63.00 | - | -51.2 Thousand |
| Earnings before Tax | -2.93 Million | -2.11 Million | -3280.00 | -4267.00 |
| Net Income | -2.93 Million | -2.11 Million | -3280.00 | -4267.00 |
| Earnings Per Share Basic | -0.60 | -0.36 | -0.00 | -0.00 |
| Earnings Per Share Diluted | -0.60 | -0.29 | -0.00 | -0.00 |
| Weighted Average Shares Outstanding | 4.87 Million | 5.86 Million | 7.28 Million | 5.97 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.87 Million | 7.28 Million | 7.28 Million | 5.97 Million |
| Gross Margin | 0.26 | 0.19 | 0.31 | - |
| EBIT Margin | -0.51 | -0.37 | -0.00 | - |
| Profit Margin | -0.53 | -0.38 | -0.00 | - |
| EBITDA | -2.83 Million | -2.07 Million | -3073.00 | -4270.00 |
| Earnings Before Tax Margin | -0.52 | -0.37 | -0.00 | - |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.25 Million | 1.96 Million | 1.75 Million | 1.76 Million | 5.51 Million | 1.58 Million |
| Cost of Revenue | 1.58 Million | 2.48 Million | 1.57 Million | 1.18 Million | 4.1 Million | 1.02 Million |
| Gross Profit | 668.29 Thousand | -514.43 Thousand | 179.28 Thousand | 582.04 Thousand | 1.41 Million | 554.54 Thousand |
| Operating Expenses | 1.09 Million | 875.92 Thousand | 1.58 Million | 1.56 Million | 4.29 Million | 897.55 Thousand |
| Selling, General and Administrative Expenses | 288.3 Thousand | 598.02 Thousand | 1.29 Million | 1.31 Million | - | 885.2 Thousand |
| Research and Development Expenses | 34.82 Thousand | 277.89 Thousand | 277.54 Thousand | 240.04 Thousand | - | - |
| Other Expenses | 774.08 Thousand | 17.37 Thousand | - | - | - | 663.47 Thousand |
| Cost and Expenses | 2.68 Million | 3.36 Million | 3.15 Million | 2.75 Million | 8.4 Million | 1.92 Million |
| Operating Income | -428.91 Thousand | -1.39 Million | -1.44 Million | -986.15 Thousand | -2.88 Million | -343.01 Thousand |
| Interest Expense | - | 3729.00 | 4077.00 | 9237.00 | 53.68 Thousand | 14.18 Thousand |
| Income Tax Expense | -25.54 Thousand | -4.00 | 4077.00 | 116.00 | 2942.00 | 2820.00 |
| Earnings before Tax | -417.53 Thousand | -1.39 Million | -1.44 Million | -995.27 Thousand | -2.93 Million | -354.37 Thousand |
| Net Income | -417.53 Thousand | -1.39 Million | -1.44 Million | -995.27 Thousand | -2.93 Million | -354.37 Thousand |
| Earnings Per Share Basic | -0.06 | -0.21 | -0.22 | -0.15 | - | -0.08 |
| Earnings Per Share Diluted | -0.06 | -0.21 | -0.22 | -0.15 | - | -0.08 |
| Weighted Average Shares Outstanding | 6.6 Million | 6.6 Million | 6.49 Million | 6.42 Million | 4.87 Million | 4.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.6 Million | 6.6 Million | 6.49 Million | 6.42 Million | 4.87 Million | 4.36 Million |
| Gross Margin | 0.30 | -0.26 | 0.10 | 0.33 | 0.26 | 0.35 |
| EBIT Margin | -0.19 | -0.70 | -0.79 | -0.55 | - | -0.21 |
| Profit Margin | -0.19 | -0.71 | -0.83 | -0.56 | -0.53 | -0.22 |
| EBITDA | -428.91 Thousand | -1.37 Million | -1.39 Million | -973.68 Thousand | - | -327.83 Thousand |
| Earnings Before Tax Margin | -0.19 | -0.71 | -0.82 | -0.56 | -0.52 | -0.22 |
LEGH
002953
AMKAF
8942
MPL
STRR